116 related articles for article (PubMed ID: 28849123)
1. Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.
Wu M; Wu Y; Qian H; Tao Y; Pang J; Wang Y; Chen Y
Mol Med Rep; 2017 Oct; 16(4):5729-5737. PubMed ID: 28849123
[TBL] [Abstract][Full Text] [Related]
2. Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells.
Cao ZH; Tao Y; Sang JR; Gu YJ; Bian XJ; Chen YC
Mol Med Rep; 2013 Apr; 7(4):1229-34. PubMed ID: 23404188
[TBL] [Abstract][Full Text] [Related]
3. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
4. Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.
Li D; Hua Y; Jiang L; Huang Y; Yue J; Wu Y; Chen Y
Med Sci Monit; 2018 Apr; 24():1997-2002. PubMed ID: 29617357
[TBL] [Abstract][Full Text] [Related]
5. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
[TBL] [Abstract][Full Text] [Related]
6. Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells.
Zhu M; Yao X; Wu M; Qian H; Wu Y; Chen Y
Mol Med Rep; 2016 Feb; 13(2):1909-13. PubMed ID: 26676300
[TBL] [Abstract][Full Text] [Related]
7. Type II cGMP-dependent protein kinase inhibits ERK/JNK-mediated activation of transcription factors in gastric cancer cells.
Sang J; Chen Y; Jiang L; Tao Y; Wu Y; Wang Y; Li Y; Lan T; Shao G
Mol Med Rep; 2012 Nov; 6(5):1190-4. PubMed ID: 22940826
[TBL] [Abstract][Full Text] [Related]
8. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H
Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906
[TBL] [Abstract][Full Text] [Related]
9. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.
Qian H; Tao Y; Jiang L; Wang Y; Lan T; Wu M; Pang J; Appiah-Kubi K; Chen Y; Wu Y
Cell Biol Int; 2018 Apr; 42(4):435-442. PubMed ID: 29150923
[TBL] [Abstract][Full Text] [Related]
10. PKG II inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRβ in gastric cancer cells.
Wang Y; Appiah-Kubi K; Lan T; Wu M; Pang J; Qian H; Tao Y; Jiang L; Wu Y; Chen Y
Cell Biol Int; 2018 Sep; 42(10):1358-1369. PubMed ID: 29935031
[TBL] [Abstract][Full Text] [Related]
11. Active PKG II inhibited the growth and migration of ovarian cancer cells through blocking Raf/MEK and PI3K/Akt signaling pathways.
Wu Y; Cai Q; Li W; Cai Z; Liu Y; Li H; Pang J; Chen Y
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31350342
[TBL] [Abstract][Full Text] [Related]
12. Type II cGMP-dependent protein kinase inhibits epidermal growth factor-induced phosphatidylinositol-3-kinase/Akt signal transduction in gastric cancer cells.
Wu M; Chen Y; Jiang L; Li Y; Lan T; Wang Y; Qian H
Oncol Lett; 2013 Dec; 6(6):1723-1728. PubMed ID: 24273605
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase.
Yao X; Wu Y; Zhu M; Qian H; Chen Y
Oncol Lett; 2015 Jul; 10(1):479-484. PubMed ID: 26171055
[TBL] [Abstract][Full Text] [Related]
14. Type II cGMP-dependent protein kinase inhibits EGF-triggered signal transduction of the MAPK/ERK-mediated pathway in gastric cancer cells.
Wu Y; Chen Y; Qu R; Lan T; Sang J
Oncol Rep; 2012 Feb; 27(2):553-8. PubMed ID: 22012247
[TBL] [Abstract][Full Text] [Related]
15. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits epidermal growth factor receptor activation in different cancer cell lines.
Jiang LU; Wu M; Wu Y; Lan T; Wang Y; Qian H; Chen Y
Oncol Lett; 2015 Jun; 9(6):2781-2786. PubMed ID: 26137146
[TBL] [Abstract][Full Text] [Related]
16. Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells.
Wang Y; Chen Y; Li Y; Lan T; Qian H
Mol Med Rep; 2014 Apr; 9(4):1444-52. PubMed ID: 24549567
[TBL] [Abstract][Full Text] [Related]
17. Type II cyclic guanosine monophosphate-dependent protein kinase inhibits Rac1 activation in gastric cancer cells.
Wang Y; Chen Y; Wu M; Lan T; Wu Y; Li Y; Qian H
Oncol Lett; 2015 Jul; 10(1):502-508. PubMed ID: 26171059
[TBL] [Abstract][Full Text] [Related]
18. PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.
Wu Y; Yao X; Zhu M; Qian H; Jiang L; Lan T; Wu M; Pang J; Chen Y
Oncotarget; 2016 Jun; 7(23):34190-200. PubMed ID: 27147579
[TBL] [Abstract][Full Text] [Related]
19. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.
Lan T; Pang J; Wang Z; Wang Y; Qian H; Chen Y; Wu Y
Biochem Biophys Res Commun; 2019 Oct; 518(1):14-18. PubMed ID: 31395339
[TBL] [Abstract][Full Text] [Related]
20. Protein Kinases Type II (PKG II) Combined with L-Arginine Significantly Ameliorated Xenograft Tumor Development: Is L-Arginine a Potential Alternative in PKG II Activation?
Wu Y; Liu Y; Cai Z; Qin H; Li H; Su W; Wang Y; Qian H; Jiang L; Wu M; Pang J; Chen Y
Med Sci Monit; 2018 Feb; 24():736-742. PubMed ID: 29401205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
